SPONSOR
BioLab Holdings
Total Trials
2
Recruiting
2
Phases
Phase 4
Conditions studied: Diabetic Foot UlcerFoot Ulcer ChronicDFUUlcer FootVenous Leg Ulcer (VLU)Venous Leg UlcerVenous UlcerLeg UlcersUlcerDiabetic Foot
BioLab Holdings is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Diabetic Foot Ulcer, Foot Ulcer Chronic, DFU, Ulcer Foot.
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — BioLab Holdings
How many clinical trials has BioLab Holdings sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by BioLab Holdings, of which 2 are actively recruiting participants. These trials cover conditions including Diabetic Foot Ulcer, Foot Ulcer Chronic, DFU. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does BioLab Holdings research focus on?
BioLab Holdings clinical trials span Diabetic Foot Ulcer, Foot Ulcer Chronic, DFU, Ulcer Foot, Venous Leg Ulcer (VLU), and additional conditions. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a BioLab Holdings clinical trial?
To participate in a BioLab Holdings trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all BioLab Holdings trials with current recruitment status updated daily.
Clinical Trials by BioLab Holdings
NCT07364630 Phase 4
Recruiting
A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers.
Diabetic Foot Ulcer
NCT07089602 Phase 4
Recruiting
Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers
Diabetic Foot
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology